ACUR
Acura Pharmaceuticals
ACUR
ACUR
Delisted
ACUR was delisted on the 22nd of February, 2017.
28 hedge funds and large institutions have $8.96M invested in Acura Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
28
Holding in Top 10
1
Calls
$14K
Puts
–
Top Buyers
| 1 | +$25.1K | |
| 2 | +$10.7K | |
| 3 | +$9.3K | |
| 4 |
SIM
Spark Investment Management
New York
|
+$8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.72K |
Top Sellers
| 1 | -$32K | |
| 2 | -$18K | |
| 3 | -$18K | |
| 4 |
OC
Oppenheimer & Co
New York
|
-$16K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$12.1K |